BACKGROUND: The importance of IL-13 in the asthma paradigm is supported by increased expression in human subjects, particularly in patients with mild-to-moderate asthma. However, the role of IL-13 in severe asthma needs to be further defined. OBJECTIVE: We sought to assess IL-13 expression in sputum and bronchial biopsy specimens from subjects with mild-to-severe asthma. METHODS: Sputum IL-13 concentrations were measured in 32 control subjects, 34 subjects with mild asthma, 21 subjects with moderate asthma, and 26 subjects with severe asthma. Enumeration of mast cells, eosinophils, and IL-13+ cells in the bronchial submucosa and airway smooth muscle (ASM) bundle was performed in 7 control subjects, 14 subjects with mild asthma, 7 subjects with moderate asthma, and 7 subjects with severe asthma. RESULTS: The proportion of subjects with measurable IL-13 in the sputum was increased in the mild asthma group (15/34) and severe asthma group (10/26) compared with that seen in the control group (4/32; P = .004). IL-13+ cells were increased within the submucosa in all asthma severity groups compared with control subjects (P = .006). The number of IL-13+ cells were increased within the ASM bundle in the severe asthma group compared with that seen in the other groups (P < .05). Asthma control questionnaire scores positively correlated with sputum IL-13 concentrations (R(s) = 0.35, P = .04) and mast cells in the ASM bundle (R(s) = 0.7, P = .007). IL-13+ cells within the submucosa and ASM correlated with sputum eosinophilia (R(s) = 0.4, P < or = .05). CONCLUSIONS: IL-13 overexpression in sputum and bronchial biopsy specimens is a feature of severe asthma.
BACKGROUND: The importance of IL-13 in the asthma paradigm is supported by increased expression in human subjects, particularly in patients with mild-to-moderate asthma. However, the role of IL-13 in severe asthma needs to be further defined. OBJECTIVE: We sought to assess IL-13 expression in sputum and bronchial biopsy specimens from subjects with mild-to-severe asthma. METHODS: Sputum IL-13 concentrations were measured in 32 control subjects, 34 subjects with mild asthma, 21 subjects with moderate asthma, and 26 subjects with severe asthma. Enumeration of mast cells, eosinophils, and IL-13+ cells in the bronchial submucosa and airway smooth muscle (ASM) bundle was performed in 7 control subjects, 14 subjects with mild asthma, 7 subjects with moderate asthma, and 7 subjects with severe asthma. RESULTS: The proportion of subjects with measurable IL-13 in the sputum was increased in the mild asthma group (15/34) and severe asthma group (10/26) compared with that seen in the control group (4/32; P = .004). IL-13+ cells were increased within the submucosa in all asthma severity groups compared with control subjects (P = .006). The number of IL-13+ cells were increased within the ASM bundle in the severe asthma group compared with that seen in the other groups (P < .05). Asthma control questionnaire scores positively correlated with sputum IL-13 concentrations (R(s) = 0.35, P = .04) and mast cells in the ASM bundle (R(s) = 0.7, P = .007). IL-13+ cells within the submucosa and ASM correlated with sputum eosinophilia (R(s) = 0.4, P < or = .05). CONCLUSIONS:IL-13 overexpression in sputum and bronchial biopsy specimens is a feature of severe asthma.
Authors: T C van der Pouw Kraan; A van Veen; L C Boeije; S A van Tuyl; E R de Groot; S O Stapel; A Bakker; C L Verweij; L A Aarden; J S van der Zee Journal: Genes Immun Date: 1999-09 Impact factor: 2.676
Authors: M M Grunstein; H Hakonarson; J Leiter; M Chen; R Whelan; J S Grunstein; S Chuang Journal: Am J Physiol Lung Cell Mol Physiol Date: 2002-03 Impact factor: 5.464
Authors: J C Laporte; P E Moore; S Baraldo; M H Jouvin; T L Church; I N Schwartzman; R A Panettieri; J P Kinet; S A Shore Journal: Am J Respir Crit Care Med Date: 2001-07-01 Impact factor: 21.405
Authors: Christopher E Brightling; Peter Bradding; Fiona A Symon; Stephen T Holgate; Andrew J Wardlaw; Ian D Pavord Journal: N Engl J Med Date: 2002-05-30 Impact factor: 91.245
Authors: M Komai-Koma; A McKay; L Thomson; C McSharry; G W Chalmers; F Y Liew; N C Thomson Journal: Clin Exp Allergy Date: 2001-09 Impact factor: 5.018
Authors: T D Howard; P A Whittaker; A L Zaiman; G H Koppelman; J Xu; M T Hanley; D A Meyers; D S Postma; E R Bleecker Journal: Am J Respir Cell Mol Biol Date: 2001-09 Impact factor: 6.914
Authors: David F Choy; Barmak Modrek; Alexander R Abbas; Sarah Kummerfeld; Hilary F Clark; Lawren C Wu; Grazyna Fedorowicz; Zora Modrusan; John V Fahy; Prescott G Woodruff; Joseph R Arron Journal: J Immunol Date: 2010-12-27 Impact factor: 5.422
Authors: Salman Siddiqui; Glenn Cruse; Susan McKenna; William Monteiro; Vijay Mistry; Andrew Wardlaw; Christopher Brightling Journal: BMC Pulm Med Date: 2009-07-14 Impact factor: 3.317